FDA Warning Letter — Adnan M. Dahdul, M.D.

Case 719607 — FEI 3029839240

The FDA took a Warning Letter action against Adnan M. Dahdul, M.D. on March 12, 2026 (Springfield, MA). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Adnan M. Dahdul, M.D.
Date
March 12, 2026
Fiscal Year
2026
Product Type
Biologics
Center
CBER
Location
Springfield, MA (United States)